Key statistics
On Tuesday, ADMA Biologics Inc (ADMA:NMQ) closed at 16.28, 20.59% above the 52 week low of 13.50 set on Mar 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 16.48 |
|---|---|
| High | 16.65 |
| Low | 16.21 |
| Bid | 16.08 |
| Offer | 16.50 |
| Previous close | 16.37 |
| Average volume | 1.83m |
|---|---|
| Shares outstanding | 238.00m |
| Free float | 228.60m |
| P/E (TTM) | 19.31 |
| Market cap | 3.90bn USD |
| EPS (TTM) | 0.8476 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Announcements
- ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
- ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
- ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
- ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
- ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
- ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
- ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
- ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
- ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
- ADMA Biologics Statement on Tariffs
More ▼
